Minerva Neurosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Minerva Neurosciences Inc.
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
/ 
Frequently asked questions
To buy Minerva Neurosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Minerva Neurosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Minerva Neurosciences Inc. is NERV:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Minerva Neurosciences Inc. has its primary listing on NASDAQ. You can trade Minerva Neurosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Minerva Neurosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Minerva Neurosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Minerva Neurosciences Inc..